A Study to Explore Pharmacokinetics/Pharmacodynamics and Safety of Tegoprazan BID Dosing in Healthy Subjects

NCT04587011 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Tegoprazan dose A or placebo
DRUG: Tegoprazan dose B or placebo
DRUG: Tegoprazan dose C or placebo
DRUG: Tegoprazan dose D or placebo

Sponsor

HK inno.N Corporation